Tecogen (Tecogen) Debt-to-Equity

: 0.10 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

Tecogen's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.80 Mil. Tecogen's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.68 Mil. Tecogen's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $14.75 Mil. Tecogen's debt to equity for the quarter that ended in Dec. 2023 was 0.10.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tecogen's Debt-to-Equity or its related term are showing as below:

TGEN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.15 Max: 0.49
Current: 0.1

During the past 13 years, the highest Debt-to-Equity Ratio of Tecogen was 0.49. The lowest was 0.03. And the median was 0.15.

TGEN's Debt-to-Equity is ranked better than
74.78% of 2617 companies
in the Industrial Products industry
Industry Median: 0.29 vs TGEN: 0.10

Tecogen Debt-to-Equity Historical Data

The historical data trend for Tecogen's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.20

0.21

0.09

0.07

0.10

Tecogen Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																0.07	0.07	0.06	0.05	0.10

Competitive Comparison

For the Electrical Equipment & Parts subindustry, Tecogen's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tecogen Debt-to-Equity Distribution

For the Industrial Products industry and Industrials sector, Tecogen's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tecogen's Debt-to-Equity falls into.

Tecogen Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tecogen's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.795	+	0.683)	/	14.747
	=	0.10

Tecogen's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.795	+	0.683)	/	14.747
	=	0.10

Tecogen (OTCPK:TGEN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Tecogen Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tecogen's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tecogen (Tecogen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Tecogen Inc (OTCPK:TGEN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

2T1:Germany

Address

45 First Avenue, Waltham, MA, USA, 02451

Website

https://www.tecogen.com

Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production. Products segment designs, manufactures and sells industrial and commercial cogeneration systems. Services segment provides operations and maintenance services and turn-key installation for products under long term service contracts. Energy Production segment sells energy in the form of electricity, heat, hot water and cooling to the customers under long-term energy sales agreements.

Executives

Earl R Lewis	director	C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
John Hatsopoulos	director, 10 percent owner, officer: Chief Executive Officer	85 FIRST AVENUE, WALTHAM MA 02451
Susan B Hirsch	director	280 OLD SOMERSET ROAD, WATCHUNG NJ 07069
Abinand Rangesh	director, officer: Chief Financial Officer	45 FIRST AVE, WALTHAM MA 02451
John M Albertine	director	100 FEDERAL DRIVE, FREDERICKSBURG VA 22405
Pacheco Ann Marie Brown	10 percent owner, other: Trustee	C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
Ralph Jenkins	director	45 FIRST AVE, WALTHAM MA 02451
Fred Holubow	director
Locke M. Benjamin	officer: Co-CEO	45 FIRST AVE, WALTHAM MA 02451
Whiting John Kimball Iv	officer: General Counsel & Secretary	49 L STREET, UNIT 9, BOSTON MA 02127
Deanna M Petersen	director	45 FIRST AVENUE, WALTHAM MA 02451
Yiannis Monovoukas	10 percent owner	TEI BIOSCIENCES, INC., 7 ELKINS STREET, BOSTON MA 02127
Charlest Maxwell	director	6100 NORTH WESTERN AVE, OKLAHOMA CITY OK 73118
Keith Davidson	director	C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
David A Garrison	officer: CFO, Treasurer and Secretary	C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420